Latest Share Chat

REMOVE ADS

Scancell Holdings Share News (SCLP)

Scancell Holdings Information

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes

Get Live Data

22.50 0.10 (0.44%)

Bid:

22.00

Ask:

23.00

Spread: 1.00 (4.545%)

Market Cap: £234.54m

Last checked at -

Intraday Scancell Holdings Share Chart

REMOVE ADS

Scancell Holdings News

Scancell reports progress across a number of trials

Scancell, which develops novel immunotherapies for the treatment of cancer, on Tuesday revealed that four out of the six evaluable patients treated wi...

Scancell secures Australian patent

Scancell said it had received a patent for its DNA ImmunoBody treatment in Australia. Australia is the first jurisdiction to approve the DNA patent...

Scancell DNA Immunotherapy Technology Granted Patent In Australia

SABMilller Chairman sells over 11m pounds in shares

Graham Mackay, the Chairman of SABMiller who is currently on a medical leave of absence due to a brain tumour, has sold over 11m pounds-worth of share...

Scancell shares healthy following patent approval award in Japan

Shares in cancer vaccine developer Scancell rose on Wednesday after the company announced its ImmunoBody Patent had been approved in Japan. The same ...

Sector movers: Pharmaceuticals under the weather as AstraZeneca takes a hit

The pharmaceuticals and biotechnology sector was at the bottom of the pile on Thursday after a disappointing set of full-year results from AstraZeneca...

Six month operating loss increases slightly at Scancell

AIM-listed medical company Scancell has published its unaudited interim results for the six month period to October 31st, showing an overall operatin...

Scancell Holdings updates on clinical trial of melanoma vaccine

Scancell Holdings said Tuesday it edged closer to completing clinical trials of a vaccine for the treatment of melanoma. The developer of therapeuti...